| For: | Andaluz-Ojeda D, Vidal-Cortes P, Aparisi Sanz Á, Suberviola B, Del Río Carbajo L, Nogales Martín L, Prol Silva E, Nieto del Olmo J, Barberán J, Cusacovich I. Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review. World J Crit Care Med 2022; 11(4): 269-297 [PMID: 36051937 DOI: 10.5492/wjccm.v11.i4.269] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3141/full/v11/i4/269.htm |
| Number | Citing Articles |
| 1 |
Renata Esposito, Davida Mirra, Liberata Sportiello, Giuseppe Spaziano, Bruno D’Agostino. Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?. Biomedicines 2022; 10(11) doi: 10.3390/biomedicines10112815
|
| 2 |
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, Geetika Kaur, Reetesh Kumar, Talha Bin Emran. Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword. Immunity, Inflammation and Disease 2023; 11(9) doi: 10.1002/iid3.1020
|
| 3 |
Russka Shumnalieva, Metodija Sekulovski, Monika Peshevska-Sekulovska, Anita Aleksandrova, Hristo Valkov, Tsvetelina Velikova. Harnessing immunity: Immunomodulatory therapies in COVID-19. World Journal of Virology 2024; 13(2): 92521 doi: 10.5501/wjv.v13.i2.92521
|
| 4 |
Salvatore Vaiasicca, David W. James, Gianmarco Melone, Omar Saeed, Lewis W. Francis, Bruna Corradetti. Amniotic fluid-derived mesenchymal stem cells as a therapeutic tool against cytokine storm: a comparison with umbilical cord counterparts. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04262-0
|